Published in Medical Letter on the CDC and FDA, June 8th, 2008
"IDE approval is a major milestone for our company and represents a tremendous accomplishment for our management team, business partners, and clinical and scientific advisors," said Gary Sabins, President and CEO of Spinal Restoration, Inc. "Based upon available data and results from our preclinical testing, we are confident that this clinical study will support the safety and efficacy of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.